Celacade

From WikiMD.org
Jump to navigation Jump to search

Celacade

Celacade (pronounced: /sɛləkeɪd/) is a medical treatment developed by Vasogen Inc. It is designed to modulate the immune system and is used in the treatment of chronic heart failure and peripheral artery disease.

Etymology

The term "Celacade" is a proprietary name and its etymology is not publicly disclosed. It is likely derived from the words "cell" and "cascade", referring to the treatment's mechanism of action on the body's cells.

Mechanism of Action

Celacade works by modulating the immune system. It involves the extraction of a small amount of the patient's blood, which is then treated with ozone and ultraviolet light. This process is believed to induce a controlled oxidative stress, which when re-infused into the patient, triggers an immune response that leads to anti-inflammatory effects.

Related Terms

  • Chronic Heart Failure: A condition where the heart is unable to pump enough blood to meet the body's needs. Celacade is used as a treatment for this condition.
  • Peripheral Artery Disease: A circulatory condition in which narrowed blood vessels reduce blood flow to the limbs. Celacade is also used in the treatment of this disease.
  • Vasogen Inc: The company that developed Celacade.
  • Ozone Therapy: A form of alternative medicine treatment that purports to increase the amount of oxygen in the body through the introduction of ozone. This is similar to the process used in Celacade treatment.
  • Ultraviolet Light Therapy: A treatment used in dermatology that uses UV light to treat skin conditions. This is also similar to the process used in Celacade treatment.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski